Amy DeZern
Professor of Oncology and Medicine, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins · Stanford Health Care
Credentials: · · · · ·
History
- Present
- 2009–2011
Medical Oncology
- 2008–2009
Hematology

- 2001–2005
Research
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
New England Journal of Medicine · 2020 · 449 citations
Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
Journal of Clinical Oncology · 2021 · 429 citations
Paroxysmal nocturnal haemoglobinuria
Review · Nature Reviews Disease Primers · 2017 · 370 citations

65 papers
- RK
60 papers

47 papers

42 papers
- ML
41 papers
- IG
40 papers

37 papers · 2 as a fellow
- DS
36 papers
Grants
- 2022–2026
Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS
National Heart, Lung, and Blood Institute · R01
PI · $1.6M · Johns Hopkins University
- 2021–2022
Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS
National Heart, Lung, and Blood Institute · R56
PI · $409.4K · Johns Hopkins University
- 2017–2019
Advancing Diagnostics and Therapeutics in Bone Marrow Failure
National Heart, Lung, and Blood Institute · R03
Contact PI · $163.6K · Johns Hopkins University
- 2014–2018
Advancing Diagnostics and Therapeutics in Bone Marrow Failure
National Heart, Lung, and Blood Institute · K23
Contact PI · $636.9K · Johns Hopkins University
Clinical trials
- 2016–2021
NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2015–2021
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2014–2021
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2014–2015
Red Cell Transfusion Goals in Patients With Acute Leukemias
Principal investigator · Completed · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

